Clinical and Experimental Hepatology

Abstract

1/2019 vol. 5
Review paper

An updated review of cystic hepatic lesions

  1. Department of Medicine/Hospitalist, Sovah Health, Martinsville, VA, United States
  2. Gastroenterology & Hepatology Attending Physician, Mercy Medical Center, Des Moines, IA, United States
  3. Junior Resident, Medical Intensive Care Unit, St. John’s Medical College, Bengaluru, India
  4. Department of Clinical Pharmacology, Seth GS Medical College & King Edward Memorial Hospital, Mumbai, India
Clin Exp HEPATOL 2019; 5, 1: 22–29
Online publish date: 2019/03/01
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Cystic hepatic lesions are commonly encountered in daily practice. The diagnosis of these lesions ranges from benign lesions of no clinical significance to malignant and potentially lethal conditions. The prevalence of hepatic cyst (HC) has been reported to be as high as 15-18% in the United States. Imaging with conventional ultrasound, computed tomography, magnetic resonance imaging, or contrast-enhanced ultrasound can be used to characterize further and diagnose. The pre-test probability of a diagnosis is highly affected by the patient’s comorbidities and the clinical and laboratory data; thus, imaging studies should be interpreted in the context of the other clinical information for that particular patient. Treatment modalities for hepatic cyst include fenestration, aspiration sclerotherapy, or surgical resection. In the current review, we discuss the pathophysiology, diagnosis, and treatment modalities for various cystic hepatic lesions.
Share